業績

論文

2022年

Kato D, Mitsuhashi S, Miya F, Saitoh S, Okamoto N, Tsunoda T, Kochi Y.
Utility of tissue-specific gene expression scores for gene prioritization in Mendelian diseases.
J Hum Genet, 2022 Dec;67(12)739-742. doi: 10.1038/s10038-022-01071-8.

https://www.nature.com/articles/s10038-022-01071-8


Ueda T, Takaishi S, Yoshie T, Usuki N, Tatsuno K, Ohtsubo H, Araga T, Kaga Y, Takada T.
Long-term outcome and factors associated with restenosis after combination therapy of balloon angioplasty and stenting for symptomatic intracranial stenosis.
BMC Neurol, 2022 Dec;22(1):477

https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-022-03009-1


Komine Y, Shimizu T, Akiyama H, Hagiwara Y, Fukano T, Kuwata C, Hasegawa Y, Yamano Y.

The Usefulness of Heart Rate Variability Spectral Analysis in Detecting Covert Atrial
Fibrillation Among Patients with Cryptogenic Stroke.
St. Marianna Med. J,2022 in press


Kaburagi K, Shimizu T, Hagiwara Y, Fukano T, Shibata S, Hoshino M, Sasaki N, Akiyama H, Hasegawa Y, Yamano Y.

Usefulness of carotid duplex ultrasonography in predicting residual large-vessel occlusions after intravenous recombinant tissue plasminogen activator therapy in patients with acute ischemic stroke.
J Med Ultrason (2001), in press doi: 10.1007/s10396-022-01271-x.

Usefulness of carotid duplex ultrasonography in predicting residual large-vessel occlusions after intravenous recombinant tissue plasminogen activator therapy in patients with acute ischemic stroke (springernature.app)


Shibata S, Sakurai K, Tachikawa K, Ko R, Hino S, Fukano T, Isahaya K, Haraguchi T, Yamauchi J, Tanabe K, Nagasaka M, Hagiwara Y, Shimizu T, Akiyama H, Kobayashi Y, Hasegawa Y, Yamano Y.

The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy.
Neurol Int, 2022 Dec;14(4):981-990

https://www.mdpi.com/2035-8377/14/4/77

big_cover-neurolint-v14-i4.png (1748×2480) (mdpi.com)


Kikuchi T, Takao N, Sato T, Isahaya K, Hino S, Kaburagi M, Tachikawa K, Ko R, Shibata S, Kaburagi K, Iijima N, Mizukami H, Sakurai K, Yamauchi J, Kimura A, Shimohata T, Yamano Y.

The level of CSF CXCL10 is highly elevated and decreased after steroid therapy in patients with autoimmune glial fibrillary acidic protein astrocytopathy.
Clin. Exp. Neuroimmunol, 2022 Early View

https://onlinelibrary.wiley.com/doi/abs/10.1111/cen3.12732


Matsumoto H, Shiraishi M, Higashi A, Hino S, Kaburagi M, Mizukami H, Maki F, Yamauchi J, Tanabe K, Sato T, Yamano Y.
The Forward and Lateral Tilt Angle of the Neck and Trunk Measured by Three-Dimensional Gait and Motion Analysis as a Candidate for a Severity Index in Patients with Parkinson's Disease.
Neurol Int, 2022;14(3):727-737

https://www.mdpi.com/2035-8377/14/3/61

big_cover-neurolint-v14-i3.png (1748×2480) (mdpi.com)


Nozuma S, Matsuura E, Tashiro Y, Nagata R, Ando M, Hiramatsu Y, Higuchi Y, Sakiyama Y, Hashiguchi A, Michizono K, Higashi K, Matsuzaki T, Kodama D, Tanaka M, Yamano Y, Moritoyo T, Kubota R, Takashima H.
Efficacy of l-Arginine Treatment in Patients with HTLV-1-Associated Neurological Disease.
Ann Clin Transl Neurol, in press


Puccioni-Sohler M, Poton AD, Cabral-Castro MJ, Yamano Y, Taylor G, Casseb J.
Human T lymphotropic virus type 1-associated myelopathy: overview of HTLV-1/2 tests and potential biomarkers.
AIDS Res Hum Retroviruses, 2022 Dec;38(12):924-932. doi: 10.1089/AID.2022.0028.

https://pubmed.ncbi.nlm.nih.gov/35819286/


Ueda T, Hasegawa Y, Takeuchi M, Morimoto M, Tsuboi Y, Yamamoto R, Kaku S, Ayabe J, AkiyamaT, Ishima D, Mori K, Kagami H, Ito H, Onodera H, Doi H, Tsumoto T, Hataoka S, Noda M, Tomura N, Masuo O, Yoshida Y, Kaga Y, Tatsuno K, Yoshie T, Takaishi S, Yamano Y.
Primary results of mechanical thrombectomy for acute ischemic stroke: The K-NET registry in the Japanese metropolitan area.
International Journal of Stroke,, 2022 Nov. DOI: 10.1177/17474930221138014


Sasaki N, Sato T, Yamatoku M, Yamano Y.
Efficacy of repetitive transcranial magnetic stimulation for gait disturbance in HTLV-1 associated myelopathy.
NeuroRehabilitation, 2022 51(3):519-526. doi: 10.3233/NRE-220105.


Tanaka Y, Sato T, Yagishita N, Yamauchi J, Araya N, Aratani S, Takahashi K, Kunitomo Y, Nagasaka M, Kanda Y, Uchimaru K, Morio T, Yamano Y.
Potential Role of HTLV-1 Tax-Specific Cytotoxic T Lymphocytes expressing a Unique T-cell Receptor to Promote Inflammation of the Central Nervous System in Myelopathy Associated with HTLV-1.
Front. Immunol, 2022 Aug;13:993025. doi: 10.3389/fimmu.2022.993025.


Yoshie T, Matsuda Y, Arakawa Y, Otsubo H, Araga T, Tatsuno K, Takaishi S, Usuki N, Ueda T.
The Influence of Experience on Gazing Patterns during Endovascular Treatment: Eye-Tracking Study.
Journal of Neuroendovascular Therapy, 2022 Jun;16(6):294-300


Hagiwara Y, Takao N, Usuki N, Yoshie T, Takaishi S, Shimizu T, Ueda T, Hasegawa Y, Yamano Y.
Carotid ultrasound using superb microvascular imaging to identify patients developing in-stent restenosis after CAS.
J Stroke Cerebrovasc Dis, 2022 Jul;31(8):106627. doi:10.1016/j.jstrokecerebrovasdis.2022.106627.

https://pubmed.ncbi.nlm.nih.gov/35797762/


Shimizu T, Ueno Y, Takeishi Y, Doijiri R, Kuriki A, Kikuno M, Takekawa H, Shimada Y, Kanemaru K, Kamiya Y, Yamaguchi E, Koga M, Ihara M, Tsujino A, Hirata K, Hasegawa Y, Hattori N, Urabe T.
Evaluating the Potential Pathology and Short-Term Outcomes of Cryptogenic Stroke Using the Etiological Classification System. doi: 10.5551/jat.63267.
J Atheroscler Thromb, 2022 in press

https://pubmed.ncbi.nlm.nih.gov/35691846/


Wada Y, Sato T, Hasegawa H, Matsudaira T, Nao N, Coler-Reilly ALG, Tasaka T, Yamauchi S, Okagawa T, Momose H, Tanio M, Kuramitsu M, Sasaki D, Matsumoto N, Yagishita N, Yamauchi J, Araya N, Tanabe K, Yamagishi M, Nakashima M, Nakahata S, Iha H, Ogata M, Muramatsu M, Imaizumi Y, Uchimaru K, Miyazaki Y, Konnai S, Yanagihara K, Morishita K, Watanabe T, Yamano Y, Saito M.
RAISING is a high-performance method for identifying random transgene integration sites.
Commun Biol, 2022 Jun;5(1):535 doi: 10.1038/s42003-022-03467-w.

https://www.nature.com/articles/s42003-022-03467-w.pdf


Imai T, Shinohara K, Uchino K, Okuma H, Maki F, Hiruma K, Ariizumi Y, Yamano Y.
Paraneoplastic cerebellar degeneration with anti-Yo antibodies and an associated submandibular gland tumor: a case report.
BMC Neurol., 2022 May;22(1):165. doi: 10.1186/s12883-022-02684-4.

https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-022-02684-4


Kamoi K, Watanabe T, Uchimaru K, Okayama A, Seiko K, Kawamata T, Kurozumi-Karube H, Horiguchi N, Zong Yuan, Yamano Y, Hamaguchi I, Nannya Y, Tojo A, and Ohno-Matsui K. Updates on HTLV-1 Uveitis.
Viruses, 2022 Apr;14(4)794 doi:10.3390/v14040794

https://www.mdpi.com/1999-4915/14/4/794


Kimura M, Yamauchi J, Sato T, Yagishita N, Araya N, Aratani S, Tanabe K, Horibe E, Watanabe T, Coler-Reilly ALG, Nagasaka M, Akasu Y, Kaburagi K, Kikuchi T, Shibata S, Matsumoto H, Koseki A, Inoue S, Takata A, Yamano Y.
Health-related quality of life evaluation using the Short Form-36 in patients with human T-lymphotropic virus type 1-associated myelopathy.
Front Med(Lausanne), 2022 Apr;9:879379. doi: 10.3389/fmed.2022.879379.

https://www.frontiersin.org/articles/10.3389/fmed.2022.879379/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Medicine&id=879379


Uchida M, Ito H, Takasuna H, Goto T, Takumi I, Fukano T, Hagiwara Y, Tanaka Y.
Initial experience with left transradial neurointerventions for cerebral aneurysms using the 6-French Simmons guiding sheath.
J Stroke Cerebrovasc Dis, 2022 Apr;31(4):106350.
doi: 10.1016/j.jstrokecerebrovasdis.2022.106350.

https://reader.elsevier.com/reader/sd/pii/S1052305722000477?token=E122BD3538E8EC5A35904EAF9C21A40EFFD4258A909075BAEB364170FE7831E633B0AB39F6014C244E1CE2A36A044C85&originRegion=us-east-1&originCreation=20220711054705


Takeda H, Imoto K, Umemoto K, Doi A, Arai H, Horie Y, Mizukami T, Oguri T, Ogura T, Izawa N,
Yamamoto H, Yamano Y, Sunakawa Y.
Clinical Utility of Genomic Profiling Tests in Patients with Advanced Gastrointestinal Cancers.
Target Oncol, 2022 Mar;17(2):177-185.

https://link.springer.com/article/10.1007/s11523-022-00871-4


Nakajima T, Yoshifuji H, Yamano Y, Yurugi K, Miura Y, Maekawa T, Yoshida T, Handa H, Ohmura K, Mimori T, Terao C.
Co-occurrence of Relapsing Polychondritis and Autoimmune Thyroid Diseases.
Orphanet J Rare Dis, 2022 May;17(1):101 doi:10.1186/s13023-022-02261-5. 

https://ojrd.biomedcentral.com/articles/10.1186/s13023-022-02261-5


Tsujikawa K, Hamanaka K, Riku Y, Hattori Y, Hara N, Iguchi Y, Ishigaki S, Hashizume A, Miyatake S, Mitsuhashi S, Miyazaki Y, Kataoka M, Jiayi L, Yasui K, Kuru S, Koike H, Kobayashi K, Sahara N, Ozaki N, Yoshida M, Kakita A, Saito Y, Iwasaki Y, Miyashita A, Iwatsubo T; Japanese Alzheimer’s
Disease Neuroimaging Initiative (J-ADNI); Ikeuchi T; Japanese Longitudinal Biomarker Study in PSP and CBD (JALPAC) Consortium; Miyata T, Sobue G, Matsumoto N, Sahashi K, Katsuno M.
Actin-binding protein filamin-A drives tau aggregation andcontributes to progressive
supranuclear palsy pathology.
Sci Adv, 2022 May:8(21):eabm5029. doi: 10.1126/sciadv.abm5029. 

https://www.science.org/doi/pdf/10.1126/sciadv.abm5029


Hamanaka K, Miyake N, Mizuguchi T, Miyatake S, Uchiyama Y, Tsuchida N, Sekiguchi F, Mitsuhashi S, Tsurusaki Y, Nakashima M, Saitsu H, Yamada K, Sakamoto M, Fukuda H, Ohori S, Saida K, Itai T, Azuma Y, Koshimizu E, Fujita A, Erturk B, Hiraki Y, Ch'ng GS, Kato M, Okamoto N, Takata A, Matsumoto N.
Large- scale discovery of novel neurodevelopmental disorder-related genes through a unified analysis of single-nucleotide and copy number variants.
Genome Med, 2022 Apr;14(1):40. doi: 10.1186/s13073-022-01042-w. 

https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-022-01042-w


Hoshino M, Sasaki R, Tsuchihashi Y, Otsuka Y, Sakurai K, Yamano Y.
A case of autoimmune encephalitis with involuntary movements as the first symptom and suspected association with mumps virus infection
Rinsho Shinkeigaku, 2022;62(2):140-144 doi:10.5692/clinicalneurol.cn-001669.


Mikami K, Shiraishi M, Kamo T.
Effect of subjective vertical perception on lateral flexion posture of patients with Parkinson's disease.
Sci Rep,, 2022 Jan;12(1):1532 doi: 10.1038/s41598-022-05587-z.

https://www.nature.com/articles/s41598-022-05587-z.pdf


Okada Y, Shiraishi M, Hori K, Yamaguchi K, Hasegawa Y.
Relationship between cerebral blood flow reduction patterns on scintigraphy and nonmotor symptoms in new-onset lewy body disease.
Nucl Med Rev,, 2022; 25(1)18-24 doi: 10.5603/NMR.a2022.0005.

https://journals.viamedica.pl/nuclear_medicine_review/article/view/84414


Yamauchi J, Tanabe K, Sato T, Nakagawa M, Matsuura E, Tsuboi Y, Tamaki K, Sakima H, Ishihara S, Ohta Y, Matsumoto N, Kono K, Yagishita N, Araya N, Takahashi K, Kunitomo Y, Nagasaka M, Coler-Reilly ALG, Hasegawa Y, Araujo A, Jacobson S, Grassi MFR, Galvão-Castro B, Bland M, Taylor GP, Martin F, Yamano Y.
Efficacy of corticosteroid therapy for HTLV-1-associated myelopathy/tropical spastic paraparesis: A randomized controlled trial (HAMLET-P).
Viruses, 2022 Jan;14(1):136

https://doi.org/10.3390/v14010136


Takao N, Yamano Y.
Forefront studies on HTLV-1-associated myelopathy/tropical spasti cparaparesis (HAM/TSP).
Clin Exp Neuroimmunol, 2022 Jan;13(1):34-41.doi: org/10.1111/cen3.12687.

https://onlinelibrary.wiley.com/doi/10.1111/cen3.12687


Shimizu J, Yamano Y, Kawahara K, Suzuki N.
Nationwide cross-sectional survey of patients with relapsing polychondritis in 2019
demonstrates reduction of airway involvement compared with that in 2009.
Sci Rep, 2022 Jan;12(1):465. doi: 10.1038/s41598-021-04493-0

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748451/pdf/41598_2021_Article_4493.pdf


櫻井謙三, 山野嘉久
神経感染症の治療の進歩(2021)
神経治療学 39(5)760-763 2022年12月


星野俊, 土橋瑶子, 佐々木梨衣, 大塚快信, 山野嘉久
新規診断基準が早期診断に有用であったCreutzfeldt-Jakob病4例の比較検討
脳神経内科, 97(6):776-782 2022年12月


秋山久尚.
慢性頭痛のオンライン診療
Medicina, 59(13):2444-2449 2022年12月


山野嘉久.
HTLV-1関連脊髄症(HAM)
CLINICAL NEUROSCIENCE, 40(11):1406-1408 2022年11月


山野嘉久. 松田文彦.
難病プラットフォームの確立と展開
臨床評価, 50(2):194-208 2022年10月


山野嘉久.
難病患者へのオンライン診療の挑戦と展望.
Medical Science Digest 48(7):16-18 2022年7月


黄世捷, 伊佐早健司.
【脳神経内科領域における医学教育の展望ーPost/with コロナ時代を見据えて】DX時代の病院と臨床教育の実践.
Brain and NERVE, 74(6):819-821 2022年6月


星野俊,清水高弘,藤井修一,柳澤俊之,長谷川泰弘,山野嘉久.
New–Onset Refractory Status Epilepticusの治療経過中に両手指足趾にテタニー様症状を呈した39歳女性例.
神経治療学, 39(1):37-41 2022年6月


鷹尾直誠, 山野嘉久.
HTLV-1関連脊髄症
CLINICAL NEUROSCIENCE, 40(6);798-800 2022年6月


今井健, 清水高広, 土橋瑶子, 赤須友香利, 秋山久尚, 山内淳司, 長谷川泰弘, 山野嘉久.
活動性担癌患者における脳梗塞発症後の死亡関連因子に関する検討.
脳卒中, 44(3):252-258 2022年5月


山野嘉久.
免疫性神経疾患(第2版)  Ⅳ. 脱髄以外の中枢神経免疫疾患
HTLV-1-associated myelopathy(HAM).
日本臨床80巻増刊号5 2022年5月


山野嘉久.
HTLV-1関連脊髄症.
内科学 第12版,306-307, 2022年3月.


清水高弘, 山野嘉久.
脳内血管.
CLINICAL NEUROSCIENCE, 40(2)161-166. 2022年2月


秋山久尚.
最新臨床脳卒中学(第2版)下 ⅩⅤⅠ. 脳梗塞各論
アテローム血栓性脳梗塞 病態生理と臨床症候
日本臨床 80巻増刊号2 2022年2月


髙石智, 吉江智秀.
診断脳血管撮影
脳神経外科速報, 32(1):21-27. 2022年1月


眞木二葉, 長谷川泰弘, 曽我海馬, 太組一朗, 松森隆史, 鈴木祐, 柳澤俊之, 山野嘉久.
視床下核脳深部刺激療法術後に病的性欲亢進をきたしたParkinson病の1例.
神経治療学, 38(3):395-398. 2022年1月


PAGE TOP